Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Other Current Receivables: ¥20 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600645 Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
65 GF Score
Price ¥20.01
GF Value ¥18.47
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Zhongyuan Union Cell & Gene Engineering Other Current Receivables?

Zhongyuan Union Cell & Gene Engineering SHSE:600645 +0.30% 65 Other Current Receivables is ¥20 Mil as of Mar. 2026. GuruFocus rates SHSE:600645 with a GF Score™ of 65/100 and a GF Value™ of ¥18.47 (Fairly Valued). The stock has 2 warning signs investors should review.

Zhongyuan Union Cell & Gene Engineering's Other Current Receivables for the quarter that ended in Mar. 2026 was ¥20 Mil.

Zhongyuan Union Cell & Gene Engineering's quarterly Other Current Receivables declined from Sep. 2025 (¥17.08 Mil) to Dec. 2025 (¥15.58 Mil) but then increased from Dec. 2025 (¥15.58 Mil) to Mar. 2026 (¥20.08 Mil).

Zhongyuan Union Cell & Gene Engineering's annual Other Current Receivables declined from Dec. 2023 (¥22.76 Mil) to Dec. 2024 (¥18.92 Mil) and declined from Dec. 2024 (¥18.92 Mil) to Dec. 2025 (¥15.58 Mil).

Zhongyuan Union Cell & Gene Engineering Other Current Receivables Related Terms

Zhongyuan Union Cell & Gene Engineering Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongyuan Union Cell & Gene Engineering Other Current Receivables Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.93 34.71 22.76 18.92 15.58

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.56 18.63 17.08 15.58 20.08
SHSE:600645
65GF Score
Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongyuan Union Cell & Gene Engineering Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ¥20 Mil mean?
Zhongyuan Union Cell & Gene Engineering (SHSE:600645) has a Other Current Receivables of ¥20 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors.
Is Zhongyuan Union Cell & Gene Engineering's Other Current Receivables too high?
Zhongyuan Union Cell & Gene Engineering's current Other Current Receivables is ¥20 Mil. Overall, Zhongyuan Union Cell & Gene Engineering has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhongyuan Union Cell & Gene Engineering's Other Current Receivables compare to VRTX and REGN?
Zhongyuan Union Cell & Gene Engineering's Other Current Receivables of ¥20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors. Zhongyuan Union Cell & Gene Engineering's current Other Current Receivables is ¥20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongyuan Union Cell & Gene Engineering stock overvalued right now?
Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering (SHSE:600645) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.47, compared to a current price of ¥20.01 — trading 8.3% above its estimated fair value. The current Other Current Receivables is ¥20 Mil. Zhongyuan Union Cell & Gene Engineering's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Zhongyuan Union Cell & Gene Engineering (SHSE:600645), the current Other Current Receivables is ¥20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering stock appears to be overvalued. The current stock price of ¥20.01 is trading 8.3% above its estimated GF Value™ of ¥18.47. GuruFocus considers Zhongyuan Union Cell & Gene Engineering to be Fairly Valued.

Key valuation signals for SHSE:600645:

  • Other Current Receivables: ¥20 Mil
  • GF Value™: ¥18.47 vs. price of ¥20.01 (8.3% above fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhongyuan Union Cell & Gene Engineering Business Description

Address 45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
65GF Score

Get the complete analysis for SHSE:600645

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.01
Price
¥18.47
GF Value